| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.9M | +0.0% |
| Cost of Revenue | $3.2M | +0.0% |
| Gross Profit | $635K | +0.0% |
| R&D Expense | $252K | -94.3% |
| SG&A Expense | $2.9M | -76.1% |
| Operating Income | -$3.4M | +85.1% |
| Interest Expense | $513K | -46.7% |
| Pre-tax Income | $9.3M | +124.5% |
| Income Tax | $20K | +0.0% |
| Net Income | $9.3M | +124.5% |
| EPS (Basic) | $0.09 | +106.9% |
| EPS (Diluted) | $0.04 | +103.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | -100.0% |
| Accounts Receivable | $1.6M | +1.8% |
| Current Assets | $1.8M | -15.7% |
| Total Assets | $2.3M | -16.9% |
| Current Liabilities | $10.5M | -55.5% |
| Long-term Debt | $2.5M | +0.0% |
| Total Liabilities | $10.5M | -59.8% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | +90.8% |
| Capital Expenditures | $34K | +0.0% |
| Investing Cash Flow | -$34K | +0.0% |
| Financing Cash Flow | $3.0M | -80.0% |
| Free Cash Flow | -$1.7M | +90.6% |
| -$8.3M |
| +64.8% |